Search | IOVS | ARVO Journals

View

Showing 1 – 16 of 16

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

RTP801i: A Novel Anti–Angiogenic Strategy Superior to and Cooperative With VEGF–A Blockade in Suppressing CNV

M. Nozaki; B.J. Raisler; I. Mett; N. Notkin; I. Papismadov; L. Shalom; A. Takeda; J.Z. Baffi; E. Feinstein; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):900. doi:

ARVO Annual Meeting Abstract May 2006

CCR3 Blockade Suppresses Experimental Choroidal Neovascularization

A. Takeda; M. Nozaki; B.J. Raisler; J.Z. Baffi; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1529. doi:

ARVO Annual Meeting Abstract May 2006

Corneal Avascularity Is Due to Soluble VEGF Receptor–1

R. Albuquerque; B. Raisler; M. Nozaki; J.Z. Baffi; A. Takeda; J.M. Collinson; L.J. Leiper; S. Ikeda; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1628. doi:

ARVO Annual Meeting Abstract May 2006

The Anti–Angiogenic Activity of Vegf–A Is Masked by the Silencing of Vegfr–1 By Sparc

B.J. Raisler; M. Nozaki; J.Z. Baffi; V. Chandrasekaran; E.W. Taylor; R. Brekken; E.H. Sage; A. Ahmed; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1830. doi:

ARVO Annual Meeting Abstract May 2006

VEGF–A Suppresses Choroidal Neovascularization via HO–1

J. Ambati; M. Nozaki; E. Sakurai; J.Z. Baffi; A. Takeda; B.J. Raisler; B.K. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1831. doi:

ARVO Annual Meeting Abstract May 2006

Activated Complement Components of Drusen Promote Choroidal Neovascularization

J.Z. Baffi; M. Nozaki; B.J. Raisler; E. Sakurai; K. Zhang; J.D. Lambris; J.V. Sarma; A. Humbles; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):860. doi:

ARVO Annual Meeting Abstract May 2005

Excess Endogenous VEGF–A Suppresses Laser–induced Choroidal Neovascularization via VEGFR–1

M. Nozaki; E. Sakurai; B.J. Raisler; J.Z. Baffi; M. Shibuya; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):470. doi:

ARVO Annual Meeting Abstract May 2005

Drusen Complement Components C3a and C5a Promote Choroidal Neovascularization

B.J. Raisler; E. Sakurai; M. Nozaki; J.Z. Baffi; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1214. doi:

ARVO Annual Meeting Abstract May 2005

Inhibition of Choroidal Neovascularization by VEGF–A Blockade Is Mediated via Ccl–2 Suppression

E. Sakurai; M. Nozaki; B.J. Raisler; J.Z. Baffi; Y. Ogura; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3027. doi:

ARVO Annual Meeting Abstract May 2005

PLGF–1 Induces Corneal Neovascularization by Silencing Soluble VEGFR–1

J.Z. Baffi; M. Nozaki; J. Witta; B.J. Raisler; S. De Falco; M. Shibuya; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4494. doi:

ARVO Annual Meeting Abstract May 2005

In situ Ablation of sFLT Disrupts the Corneal Anti–Angiogenic Barrier

B.K. Ambati; N. Singh; J. Witta; M. Nozaki; J.Z. Baffi; B. Raisler; S. Rashid; T. Suthar; A. Orecchia; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4501. doi:

ARVO Annual Meeting Abstract May 2005

Pro– and Anti–Angiogenic Actions of VEGF–A are Differentially Routed via VEGFR–1 and VEGFR–2 Through SPARC Switching

J. Ambati; M. Nozaki; E. Sakurai; B.J. Raisler; J.Z. Baffi; R.A. Brekken; E.H. Sage; M. Shibuya; B.K. Ambati

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4755. doi:

ARVO Annual Meeting Abstract May 2004

Induction of Eotaxin–3 Expression in Human Retinal Pigmented Epithelial Cells by TNF– and VEGF–A.

J.Z. Baffi; E. Sakurai; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1804. doi:

ARVO Annual Meeting Abstract May 2004

Soluble Flt–1 is present in human vitreous and is upregulated in patients with rhegmatogenous retinal detachment.

D.W. Skufca; J.Z. Baffi; A. Anand; S.J. Hasan; E. Sakurai; P.A. Pearson; B.K. Ambati; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2053. doi:

ARVO Annual Meeting Abstract May 2004

Targeted disruption of macrophage recruitment chemokines and chemokine receptors inhibits choroidal neovascularization.

E. Sakurai; J.Z. Baffi; B.K. Ambati; W.A. Kuziel; B.J. Rollins; J. Ambati

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2227. doi:

ARVO Annual Meeting Abstract May 2003

Adult Hematopoetic Stem Cells (HSC) Provide Functional Hemangioblast Activity during Choroidal Neovascularization (CNV) in Mice

J.Z. Baffi; G.A. Byrnes; J.D. Wolfe; L. Ponce; S.W. Cousins; K.G. Csaky

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1825. doi:

Advertisement